What do we know about the function of SARS-CoV-2 proteins?

被引:2
|
作者
Arevalo, Santiago Justo [1 ,2 ]
Castillo-Chavez, Adriana [1 ]
Calampa, Carmen Sofia Uribe [1 ]
Sifuentes, Daniela Zapata [1 ,2 ]
Huallpa, Cesar J. [3 ]
Bianchi, Gianfranco Landa [1 ]
Casas, Romina Garavito-Salini [1 ]
Aguilar, Mauro Quinones [1 ]
Chavarria, Roberto Pineda [1 ]
机构
[1] Univ Ricardo Palma, Fac Ciencias Biol, Lima, Peru
[2] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil
[3] Univ Nacl Agr La Molina, Fac Ciencias, Lima, Peru
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
巴西圣保罗研究基金会;
关键词
immune pathways; COVID-19; pandemic; translation inhibition; viral infection; SARS-CORONAVIRUS; STRUCTURAL BASIS; INHIBITORS; REPLICATION; REVEALS; BRAIN; NSP3;
D O I
10.3389/fimmu.2023.1249607
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The COVID-19 pandemic has highlighted the importance in the understanding of the biology of SARS-CoV-2. After more than two years since the first report of COVID-19, it remains crucial to continue studying how SARS-CoV-2 proteins interact with the host metabolism to cause COVID-19. In this review, we summarize the findings regarding the functions of the 16 non-structural, 6 accessory and 4 structural SARS-CoV-2 proteins. We place less emphasis on the spike protein, which has been the subject of several recent reviews. Furthermore, comprehensive reviews about COVID-19 therapeutic have been also published. Therefore, we do not delve into details on these topics; instead we direct the readers to those other reviews. To avoid confusions with what we know about proteins from other coronaviruses, we exclusively report findings that have been experimentally confirmed in SARS-CoV-2. We have identified host mechanisms that appear to be the primary targets of SARS-CoV-2 proteins, including gene expression and immune response pathways such as ribosome translation, JAK/STAT, RIG-1/MDA5 and NF-k beta pathways. Additionally, we emphasize the multiple functions exhibited by SARS-CoV-2 proteins, along with the limited information available for some of these proteins. Our aim with this review is to assist researchers and contribute to the ongoing comprehension of SARS-CoV-2's pathogenesis.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] What do we know about the antibody responses to SARS-CoV-2?
    Alejandro Lagunas-Rangel, Francisco
    Chavez-Valencia, Venice
    [J]. IMMUNOBIOLOGY, 2021, 226 (02)
  • [2] What do we know about the SARS-CoV-2 coronavirus in the environment?
    Nunez-Delgado, Avelino
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 727
  • [3] What we know and what we need to know about the origin of SARS-CoV-2
    Domingo, Jose L.
    [J]. ENVIRONMENTAL RESEARCH, 2021, 200
  • [4] Virus interactions with the actin cytoskeleton—what we know and do not know about SARS-CoV-2
    Malgorzata Kloc
    Ahmed Uosef
    Jarek Wosik
    Jacek Z. Kubiak
    Rafik M. Ghobrial
    [J]. Archives of Virology, 2022, 167 : 737 - 749
  • [5] SARS-CoV-2 and the Brain: What Do We Know about the Causality of 'Cognitive COVID?
    Ali Awan, Hashir
    Najmuddin Diwan, Mufaddal
    Aamir, Alifiya
    Ali, Muneeza
    Di Giannantonio, Massimo
    Ullah, Irfan
    Shoib, Sheikh
    De Berardis, Domenico
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [6] Drugs against SARS-CoV-2: What do we know about their mode of action?
    Valle, Coralie
    Martin, Baptiste
    Touret, Franck
    Shannon, Ashleigh
    Canard, Bruno
    Guillemot, Jean-Claude
    Coutard, Bruno
    Decroly, Etienne
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2020, 30 (06) : 1 - 10
  • [7] SARS-CoV-2: What do we know so far?
    Khedkar, Pratik H.
    Patzak, Andreas
    [J]. ACTA PHYSIOLOGICA, 2020, 229 (02)
  • [8] Cytokines and microRNAs in SARS-CoV-2: What do we know?
    Rarani, Fahimeh Zamani
    Rashidi, Bahman
    Abadi, Mohammad Hassan Jafari Najaf
    Hamblin, Michael R.
    Hashemian, Seyed Mohammad Reza
    Mirzaei, Hamed
    [J]. MOLECULAR THERAPY NUCLEIC ACIDS, 2022, 29 : 219 - 242
  • [9] Hearing Loss in SARS-CoV-2: What Do We Know?
    Saniasiaya, Jeyasakthy
    [J]. ENT-EAR NOSE & THROAT JOURNAL, 2021, 100 (2_SUPPL) : 152S - 154S
  • [10] Virus interactions with the actin cytoskeleton-what we know and do not know about SARS-CoV-2
    Kloc, Malgorzata
    Uosef, Ahmed
    Wosik, Jarek
    Kubiak, Jacek Z.
    Ghobrial, Rafik M.
    [J]. ARCHIVES OF VIROLOGY, 2022, 167 (03) : 737 - 749